Non-invasive assessment of liver fibrosis with FIB-4 for risk stratification and prognosis in ambulatory heart failure
Liver dysfunction is increasingly recognized as a contributor to heart failure (HF) progression and adverse outcomes. The Fibrosis-4 (FIB-4) index, a simple non-invasive marker of advanced liver fibrosis, has been validated in metabolic liver disease and associated with cardiovascular risk and mortality. In HF, F...